title: Cutaneous leishmaniasis. Treatment with itraconazole.
abstract: The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.
authors.affiliation: Department of Dermatology, S. Gerardo Hospital, Monza, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Albanese
authors.forename: P
authors.initials: P
authors.lastname: Giorgetti
authors.forename: L
authors.initials: L
authors.lastname: Santagostino
authors.forename: D
authors.initials: D
authors.lastname: Crippa
authors.forename: G
authors.initials: G
authors.lastname: Sala
mesh_terms: D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male
chemical_list: D000981:Antiprotozoal Agents; D017964:Itraconazole; D007654:Ketoconazole